Cases selected for the AskAnzal weekly PMCPA insight newsletter
Sanofiβs Dupixent website hosted a NICE guidance resource with Oct 2017 prescribing information and an HCP guide stating…
Ex-employee alleged Allergan product specialists promoted Botox via Instagram tags/hashtags linking to HCP/clinic posts. Panel found breaches, but…
LEO made a voluntary admission after five 2020 transfers of value (4 HCP, 1 HCO) were omitted from…
Ex-employee alleged CSL Viforβs non-promotional NHS service was targeted to Ferinject-using hospitals and amounted to disguised promotion/inducement. Panel…
Five weight-loss media articles were complained about. Novo Nordisk was not responsible for four. One Sunday Times interview…
An events business employee posted a public X photo where βInvokana canagliflozin tabletsβ was legible on Menariniβs stand.…
A pharmacist complained a launch letter promoted off-label use of Melatonin 1mg/ml Oral Solution. The Panel ruled the…
Roche challenged two GSK corporate press releases about lapatinib (Tykerb/Tyverb). The Panel found one release misleading on adverse…
Merz promoted Xeomin as βAt least as effective as Botox with a similar safety profileβ on an exhibition…
Anonymous alleged an AstraZeneca meeting misled attendees and promoted Seroquel for borderline personality disorder. Panel found no evidence…
One real case. One key lesson. Every week β free.